Deconvoluting the complexity of microRNAs in autophagy to improve potential cancer therapy

Cell Prolif. 2016 Oct;49(5):541-53. doi: 10.1111/cpr.12277. Epub 2016 Jul 20.

Abstract

MicroRNAs (miRNAs) (small, non-coding RNAs ∼22 nucleotides [nt] in length), have been estimated to regulate in the region of 30% of human gene expression at the post-transcriptional and translational levels. They are also involved in a series of important cellular processes, such as autophagy. Autophagy is well-known to be an evolutionarily conserved lysosomal degradation process in which a cell degrades long-lived proteins and damaged organelles. Recent evidence has shown that miRNAs can function as either oncogenes or tumour-suppressive genes in human cancers. Also, they are well-characterized to be crucial in tumourigenesis, as either oncogenes or tumour suppressors, by regulating autophagy. However, discovering the intricate mechanism of miRNA-modulated autophagy remains in its infancy. Thus, in this review, we focus on summarizing the dual function of oncogenic or tumour-suppressive miRNAs in regulation of autophagy and their roles in carcinogenesis, thereby revealing the regulatory mechanism of miRNA-modulated autophagy in cancer, to shed light on more novel RNA therapeutic strategies in the future.

Publication types

  • Review

MeSH terms

  • Animals
  • Autophagy*
  • Gene Expression Regulation, Neoplastic
  • Genes, Tumor Suppressor
  • Genetic Therapy
  • Humans
  • MicroRNAs / analysis
  • MicroRNAs / genetics*
  • MicroRNAs / metabolism
  • Neoplasms / genetics*
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Neoplasms / therapy
  • Oncogenes
  • Signal Transduction

Substances

  • MicroRNAs